AstraZeneca
AZN
#42
Rank
$318.89 B
Marketcap
$205.70
Share price
0.51%
Change (1 day)
39.94%
Change (1 year)

P/S ratio for AstraZeneca (AZN)

P/S ratio at the end of 2025: 4.90

According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.50. At the end of 2025 the company had a P/S ratio of 4.90.

P/S ratio history for AstraZeneca from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20254.9030.16%
20243.77-17.53%
20234.57-3.74%
20224.74-2.19%
20214.85-1.45%
20204.92-8.31%
20195.3725.56%
20184.2710.21%
20173.8829.36%
20163.00-14.32%
20153.503.72%
20143.3717.49%
20132.8737.02%
20122.1016.3%
20111.80-7.89%
20101.96-5.78%
20092.0810.47%
20081.88-10.96%
20072.11-31.88%
20063.10-4.92%
20053.2616.72%
20042.79-35.74%
20034.3528.55%
20023.38-31.51%
20014.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.34 16.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.55 1.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.41-55.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.45-18.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
16.0 194.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.39-56.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2.80-48.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.75-12.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.57-52.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.82-48.22%๐Ÿ‡ฌ๐Ÿ‡ง UK